1. German Diabetes Study – Baseline data of retinal layer thickness measured by <scp>SD</scp> ‐ <scp>OCT</scp> in early diabetes mellitus
- Author
-
Dan Ziegler, Oliver Kuß, Philipp Ackermann, K. Schröder, Anna Benthin, Veronika Gontscharuk, Nadine Steingrube, Rainer Guthoff, Magdalena Völker, Julia Szendroedi, Karsten Müssig, Gds Cohort, Michael Roden, Bettina Nowotny, and Gerd Geerling
- Subjects
Adult ,Male ,Retinal Ganglion Cells ,medicine.medical_specialty ,Time Factors ,Diabetic neuropathy ,Adolescent ,Visual Acuity ,Severity of Illness Index ,Young Adult ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Germany ,Ophthalmology ,Diabetes mellitus ,medicine ,Humans ,Prospective Studies ,Aged ,Retina ,Diabetic Retinopathy ,business.industry ,Incidence ,Significant difference ,Retinal ,General Medicine ,Diabetic retinopathy ,Baseline data ,Middle Aged ,medicine.disease ,Layer thickness ,Cross-Sectional Studies ,Diabetes Mellitus, Type 1 ,medicine.anatomical_structure ,Diabetes Mellitus, Type 2 ,chemistry ,Disease Progression ,030221 ophthalmology & optometry ,Female ,business ,Tomography, Optical Coherence ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Purpose Recent studies highlighted that early diabetic neurodegeneration is present before microvascular changes are visible. Retinal neurodegeneration can decrease retinal layer thickness. We aimed to determine whether decreased retinal layer thickness is present already in the early time course of disease. Methods A cross-sectional analysis of patients and healthy adults from the German Diabetes Study (GDS, ClinicalTrials.gov Identifier number: CT01055093, https://clinicaltrials.gov/ct2/show/NCT01055093). Inclusion criteria were a diagnosis of diabetes mellitus (DM) within the last 12 months. Retinal layers thickness in the nasal pericentral segment was measured by spectral domain ocular coherence tomography (SD-OCT). For statistical analysis proc mixed (sas-version 9.4) was used. Results One hundred and seventy-eight eyes of 89 patients with type 1 DM (58 males, age 36 ± 11 years, BMI 25.5 ± 4.2 kg/m²) and 242 eyes of 121 patients with type 2 DM (84 males, age 53 ± 10 years, BMI 31.9 ± 6.3 kg/m²) with a disease duration of less than 1 year were compared to 76 eyes of 38 controls (27 males, age 41 ± 16 years, BMI 27.3 ± 6.4 kg/m²). Analysis of retinal layer thickness and visual function did not reveal a significant difference between patients and controls. Conclusion In the early course of DM potential, neurodegeneration does not relate to measureable changes of retinal layer thickness.
- Published
- 2018
- Full Text
- View/download PDF